|
Volumn 64, Issue 1, 2003, Pages 60-62
|
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation
e
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CHOLESTEROL;
CLOZAPINE;
HALOPERIDOL;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
TRIACYLGLYCEROL;
ZIPRASIDONE;
ADULT;
ARTICLE;
BEHAVIOR;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MALADJUSTMENT;
MALE;
MENTAL DEFICIENCY;
METABOLIC DISORDER;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
WEIGHT GAIN;
WEIGHT REDUCTION;
|
EID: 0037266267
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v64n0112 Document Type: Article |
Times cited : (49)
|
References (9)
|